###begin article-title 0
###xml 58 62 <span type="species:ncbi:10116">Rats</span>
Lubiprostone Stimulates Duodenal Bicarbonate Secretion in Rats
###end article-title 0
###begin title 1
Background
###end title 1
###begin p 2
Lubiprostone, a bicyclic fatty acid, is used for the treatment of chronic constipation. No published study has addressed the effect of lubiprostone on intestinal ion secretion in vivo.
###end p 2
###begin title 3
Aim
###end title 3
###begin p 4
###xml 88 89 88 89 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 89 90 89 90 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
The aim of this study was to test the hypothesis that lubiprostone augments duodenal HCO3- secretion (DBS).
###end p 4
###begin title 5
Methods
###end title 5
###begin p 6
###xml 180 181 179 180 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 207 208 206 207 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 219 220 218 219 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 363 366 362 365 <sub xmlns:xlink="http://www.w3.org/1999/xlink">inh</sub>
###xml 0 3 <span type="species:ncbi:10116">Rat</span>
###xml 296 300 <span type="species:ncbi:10116">rats</span>
Rat proximal duodenal loops were perfused with pH 7.0 Krebs, control vehicle (medium-chain triglycerides), or lubiprostone (0.1-10 muM). We measured DBS with flow-through pH and CO2 electrodes, perfusate [Cl-] with a Cl- electrode, and water flux using a non-absorbable ferrocyanide marker. Some rats were pretreated with a potent, selective CFTR antagonist, CFTRinh-172 (1 mg/kg, ip), 1 h before experiments.
###end p 6
###begin title 7
Results
###end title 7
###begin p 8
###xml 81 82 81 82 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 170 173 169 172 <sub xmlns:xlink="http://www.w3.org/1999/xlink">inh</sub>
###xml 244 245 242 243 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 291 294 289 292 <sub xmlns:xlink="http://www.w3.org/1999/xlink">inh</sub>
Perfusion of lubiprostone concentration dependently increased DBS, whereas net Cl- output and net water output were only increased at 0.1 muM, compared with vehicle. CFTRinh-172 reduced lubiprostone (10 muM)-induced DBS increase, whereas net Cl- output was also unchanged. Nevertheless, CFTRinh-172 reduced basal net water output, which was reversed by lubiprostone. Furthermore, lubiprostone-induced DBS was inhibited by EP4 receptor antagonist, not by an EP1/2 receptor antagonist or by indomethacin pretreatment.
###end p 8
###begin title 9
Conclusions
###end title 9
###begin p 10
###xml 153 154 153 154 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 209 210 209 210 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 406 414 <span type="species:ncbi:9606">patients</span>
In this first study of the effect of lubiprostone on intestinal ion secretion in vivo, lubiprostone stimulated CFTR-dependent DBS without changing net Cl- secretion. This effect supports the hypothesis that Cl- secreted by CFTR is recycled across the apical membrane by anion exchangers. Recovery of water output during CFTR inhibition suggests that lubiprostone may improve the intestinal phenotype in CF patients. Furthermore, increased DBS suggests that lubiprostone may protect the duodenum from acid-induced injury via EP4 receptor activation.
###end p 10
###begin title 11
Keywords
###end title 11
###begin title 12
Introduction
###end title 12
###begin p 13
Chronic constipation is a common clinical problem. Although most cases do not reach medical attention due to the plethora of over-the-counter remedies available, severe constipation can be intractable to most remedies and, in its severe form, can be debilitating.
###end p 13
###begin p 14
###xml 961 962 961 962 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR1">1</xref>
###xml 1014 1015 1014 1015 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 757 762 <span type="species:ncbi:9606">human</span>
Recently, lubiprostone, a bicyclic fatty acid was approved by the FDA for the treatment of chronic constipation in adults. This compound appears to be in a new therapeutic class and works by a mechanism that has been described in only a few publications. In a detailed investigation of the effect of lubiprostone, Cuppoletti et al. tested the hypothesis that lubiprostone increased the activity of the chloride channel ClC-2. To test the hypothesis, they demonstrated that ClC-2 was expressed in the stomach and in the epithelial cells of the small and large intestine by PCR and in situ hybridization, and demonstrated that ClC-2 was apically expressed in transfected intestinal T84 cells. Electrophysiological measurements in T84 and in ClC-2 transfected human epithelial kidney (HEK) cell monolayers and in patch-clamped individual cells revealed that lubiprostone increased transepithelial and transmembrane currents in T84 only in ClC-2 transfected cells [1]. These data suggest that lubiprostone increases Cl- secretion by activation of the intestinal epithelial cell ClC-2 channel.
###end p 14
###begin p 15
###xml 142 143 142 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR2">2</xref>
###xml 291 292 291 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR3">3</xref>
###xml 576 577 576 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">4</xref>
###xml 578 579 578 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR6">6</xref>
Even given these compelling data, the role of ClC-2 channels in epithelial ion secretion is by no means established. First described in 1992 [2], ClC-2 channels are expressed in the stomach, intestine, colon, brain, heart, and muscle. They are part of a family of channels and transporters [3], four of which are plasma membrane expressed, with ClC-2 being the only member to which epithelial transport function is attributed. Its enterocyte expression is thought to be mostly basolateral in situ, based on studies which report localization below the junctional protein ZO-1 [4-6].
###end p 15
###begin p 16
###xml 104 105 104 105 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 216 217 216 217 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 557 558 557 558 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 703 704 703 704 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 738 739 738 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR7">7</xref>
###xml 787 788 787 788 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 800 801 800 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR8">8</xref>
###xml 822 823 822 823 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 969 970 969 970 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">9</xref>
###xml 1028 1029 1028 1029 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR1">1</xref>
###xml 451 466 <span type="species:ncbi:10090">transgenic mice</span>
###xml 488 503 <span type="species:ncbi:10090">transgenic mice</span>
###xml 586 601 <span type="species:ncbi:10090">transgenic mice</span>
###xml 644 648 <span type="species:ncbi:10090">mice</span>
The discovery that the mutations of the cystic fibrosis transmembrane regulator (CFTR), an epithelial Cl- channel, are responsible for the disease phenotype has increased interest in the function of all epithelial Cl- channels. With the discovery of ClC-2 channels, investigators hypothesized that ClC-2 function might compensate for CFTR loss-of-function, which might explain the lack of overt pulmonary or pancreatic phenotype in CFTR knockout (KO) transgenic mice. Studies of ClC-2 KO transgenic mice revealed that ClC-2 dysfunction actually increased Cl- secretion, and that double transgenic mice had a survival advantage over CFTR mutant mice, data most compatible with ClC-2 serving to recycle Cl- across the basolateral membrane [7]. Others have implicated ClC-4 in intestinal Cl- secretion [8]. Although apical Cl- channels are hypothesized to facilitate gastric HCl secretion in parietal cells, ClC-2 could not be immunolocalized in the stomach by one group [9], although gastric expression was documented by another [1].
###end p 16
###begin p 17
###xml 114 116 114 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR10">10</xref>
###xml 448 450 448 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">11</xref>
###xml 452 454 452 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">12</xref>
In one of the few published clinical studies addressing the intestinal effects of lubiprostone, Camilleri et al. [10] found that lubiprostone inhibited gastric emptying, but accelerated small and large intestinal transit, which is associated with postprandial fullness. Subsequently, investigators have reported a beneficial effect of lubiprostone in subjects with chronic constipation and functional bowel disease on the basis of clinical trials [11, 12].
###end p 17
###begin p 18
###xml 155 156 155 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">I</italic>
###xml 156 158 156 158 <sub xmlns:xlink="http://www.w3.org/1999/xlink">sc</sub>
###xml 214 216 214 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR13">13</xref>
###xml 179 189 <span type="species:ncbi:10141">guinea pig</span>
To date, one full-length published study has addressed the effects of lubiprostone on gut fluid secretion. Fei et al. reported that lubiprostone increased Isc in Ussing-chambered guinea pig distal ileum and colon [13]. Although the response was unaffected by the neurotoxin tetrodotoxin, or by EP receptor antagonists, consistent with a non-neurally and non-prostaglandin mediated mechanism, serosal application also produced a robust response, calling into question the role of ClC-2 if it was indeed apically expressed. Furthermore, the response was also inhibited by mucosal application of anion channel blockers such as glibenclamide and DIDS.
###end p 18
###begin p 19
###xml 341 342 341 342 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 342 343 342 343 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 414 416 414 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR14">14</xref>
Given the aforementioned Ussing chamber studies, functional confirmation in situ in vivo would help further understand the effect of the compound on intestinal fluid secretion. We thus propose to examine the effect of lubiprostone on fluid and electrolyte secretion in the duodenum, a locus of enterocyte anion secretion, with a focus on HCO3- secretion, which protects the mucosa from injury due to luminal acid [14]. Furthermore, given the possible confounding effect of CFTR-mediated secretion, we intend to examine the effect of acute CFTR inhibition on duodenal fluid and electrolyte secretion with a systemic, pharmacologic highly selective CFTR inhibitor.
###end p 19
###begin title 20
Methods
###end title 20
###begin title 21
Chemicals and Animals
###end title 21
###begin p 22
###xml 202 205 202 205 <sub xmlns:xlink="http://www.w3.org/1999/xlink">inh</sub>
###xml 282 284 282 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">15</xref>
###xml 346 347 346 347 <sub xmlns:xlink="http://www.w3.org/1999/xlink">6</sub>
###xml 348 350 348 350 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4&#8722;</sup>
###xml 495 496 495 496 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 648 667 <span type="species:ncbi:10116">Sprague-Dawley rats</span>
Lubiprostone (10 mg/ml in 0.04% medium-chain triglycerides (MCT) diluent Miglyol 812 N) and vehicle (MCT diluent alone) was provided from Takeda Pharmaceuticals North America, Inc. (Deerfield, IL). CFTRinh-172 was synthesized by Dr. Samedy Ouk in the Department of Chemistry, UCLA [15]. AH6809, AH23848, indomethacin, sodium ferrocyanide ([Fe(CN)6]4-), HEPES and other chemicals were obtained from Sigma Chemical (St. Louis, MO, USA). Krebs solution contained (in mM) 136 NaCl, 2.6 KCl, 1.8 CaCl2, and 10 HEPES at pH 7.0. All studies were performed with approval of the Veterans Affairs Institutional Animal Care and Use Committee (VA IACUC). Male Sprague-Dawley rats weighing 200-250 g (Harlan, San Diego, CA, USA) were fasted overnight, but had free access to water.
###end p 22
###begin title 23
###xml 27 28 27 28 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 28 29 28 29 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
Measurement of Duodenal HCO3- Secretion
###end title 23
###begin p 24
###xml 67 69 67 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR16">16</xref>
###xml 71 73 71 73 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR17">17</xref>
###xml 320 321 320 321 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 580 581 574 575 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 674 675 668 669 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 694 695 688 689 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 776 777 770 771 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 818 819 812 813 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 863 864 857 858 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 902 903 896 897 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 903 904 897 898 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 930 932 924 926 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR16">16</xref>
###xml 934 936 928 930 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR17">17</xref>
###xml 942 943 936 937 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 943 944 937 938 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 980 981 974 975 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1221 1222 1214 1215 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 1282 1283 1275 1276 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 1298 1299 1291 1292 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 1432 1433 1424 1425 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 1449 1450 1441 1442 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
Duodenal loops were prepared and perfused as previously described [16, 17]. Under isoflurane anaesthesia (2.0%), the proximal duodenal loop (perfused length 2 cm) was perfused with pH 7.0 Krebs buffer by using a peristaltic pump (Fisher Scientific, Pittsburgh, PA, USA) at 1 ml/min. The perfusate was bubbled with 100% O2, and stirred and warmed at 37degreesC with a heating stirrer (Barnstead Int., Dubuque, IA, USA). To eliminate the buffer action of perfusing chemicals, which would over- or under-estimate the titration volume using pH-stat, two sets of flow-through pH and CO2 electrodes (Lazar Lab, Los Angeles, CA) were connected in the perfusion loop where pH and CO2 concentration ([CO2]) were simultaneously and continuously measured. Since the input (perfusate) [CO2] is approximately zero, the effluent [CO2] and pH were used to calculate the total CO2 output equivalent to the secreted HCO3- as previously described [16, 17]. HCO3- secretion was expressed as total CO2 output (mumol/min/cm). The effluent was collected every 5 min in a sterilized tube on ice for water output measurement as described below. After stabilization with continuous perfusion of pH 7.0 Krebs for about 30 min, the time was set as t = 0. The duodenal loop was perfused with pH 7.0 Krebs from t = 0 min until t = 10 min (basal period). The perfusate was then changed to pH 7.0 Krebs buffer containing lubiprostone (0.1-10 muM) or vehicle from t = 10 min until t = 35 min (challenge period), with or without antagonists.
###end p 24
###begin title 25
###xml 26 27 26 27 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
Measurement of Duodenal Cl- Secretion
###end title 25
###begin p 26
###xml 2 3 2 3 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 22 23 22 23 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 87 88 87 88 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 183 184 183 184 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 219 220 219 220 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 286 287 286 287 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 309 310 309 310 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 348 349 348 349 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 407 408 407 408 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 466 467 466 467 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 490 491 490 491 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 550 551 550 551 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
Cl- concentration ([Cl-]) in the duodenal effluent was measured using a flow-through Cl--selective electrode (Lazar Lab), connected in series with the flow-through effluent unit of CO2 electrode. A standard curve for Cl- solution (2.8, 28, 280 mM) was used to calculate the effluent [Cl-]. Since perfusate [Cl-] is stable, the perfusate (input) [Cl-] was measured separately using the same electrode. Net Cl- secretion was calculated by subtracting the perfusate [Cl-] from the effluent [Cl-] with adjustment for water output, and expressed as net Cl- output (mumol/min/cm).
###end p 26
###begin title 27
Measurement of Duodenal Water Flux
###end title 27
###begin p 28
###xml 100 102 100 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR18">18</xref>
###xml 112 113 112 113 <sub xmlns:xlink="http://www.w3.org/1999/xlink">6</sub>
###xml 114 116 114 116 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4&#8722;</sup>
###xml 161 162 161 162 <sub xmlns:xlink="http://www.w3.org/1999/xlink">6</sub>
###xml 163 165 163 165 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4&#8722;</sup>
###xml 299 300 298 299 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
Water flux from the duodenal loop was measured with a non-absorbable, minimally bioreactive marker [18], [Fe(CN)6]4- (10 mM), contained in the perfusate. [Fe(CN)6]4- concentration was measured by a spectrophotometer at 320 nm absorbance. Water flux was expressed as net water output (mul/min/cm). Cl- output was adjusted according to the calculated water output.
###end p 28
###begin title 29
###xml 61 62 61 62 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 62 63 62 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 67 68 67 68 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
Effect of Lubiprostone With or Without CFTR Inhibition on HCO3-, Cl-, and Water Output
###end title 29
###begin p 30
###xml 62 63 62 63 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 63 64 63 64 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 78 79 78 79 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 209 210 208 209 <sub xmlns:xlink="http://www.w3.org/1999/xlink">6</sub>
###xml 211 213 210 212 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4&#8722;</sup>
In order to examine the effect of lubiprostone on duodenal HCO3- secretion, Cl- secretion and water flux, we first perfused lubiprostone (0.1, 1, or 10 muM) or vehicle in pH 7.0 Krebs buffer containing [Fe(CN)6]4- (10 mM).
###end p 30
###begin p 31
###xml 75 78 75 78 <sub xmlns:xlink="http://www.w3.org/1999/xlink">inh</sub>
###xml 150 153 150 153 <sub xmlns:xlink="http://www.w3.org/1999/xlink">inh</sub>
###xml 207 208 207 208 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 208 209 208 209 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 237 239 237 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">15</xref>
###xml 223 226 <span type="species:ncbi:10116">rat</span>
Some animals were pre-treated with the potent selective CFTR inhibitor CFTRinh-172 (1 mg/kg, ip) 1 h prior to the experiments. Pre-treatment with CFTRinh-172 at this concentration eliminates acid-induced HCO3- secretion in rat duodenum [15].
###end p 31
###begin title 32
###xml 61 62 61 62 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 62 63 62 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
Role of the Prostaglandin Pathway in Lubiprostone-Induced HCO3- Secretion
###end title 32
###begin p 33
###xml 159 160 159 160 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 160 161 160 161 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 221 222 220 221 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 225 226 224 225 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 277 278 276 277 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 465 467 464 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR19">19</xref>
We investigated the contribution of the prostaglandin (PG) pathway involving cyclooxygenase (COX) and E-type PG receptors (EP) towards lubiprostone-induced HCO3- secretion. Lubiprostone (10 muM) was co-perfused with an EP1/EP2 receptor antagonist AH6809 (0.1 mM) or a potent EP4 receptor antagonist AH23848 (0.1 mM). Some animals were pre-treated with the non-selective COX inhibitor indomethacin (5 mg/kg, ip) 1 h prior to the experiments as previously described [19].
###end p 33
###begin title 34
Statistics
###end title 34
###begin p 35
###xml 199 200 197 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 68 72 <span type="species:ncbi:10116">rats</span>
All data are expressed as means +/- SEM. Data were derived from six rats in each group. Comparisons between groups were made by one-way ANOVA followed by Fischer's least significant difference test. P values of 0.05 were taken as significant.
###end p 35
###begin title 36
Results
###end title 36
###begin title 37
Effect of Lubiprostone on Duodenal Ion Secretion
###end title 37
###begin p 38
###xml 74 75 73 74 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 75 76 74 75 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 130 131 129 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 154 155 153 154 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 237 238 235 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 290 291 288 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 381 382 378 379 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 446 447 442 443 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 447 448 443 444 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 514 515 510 511 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 515 516 511 512 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 523 524 519 520 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 552 553 548 549 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 553 554 549 550 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 587 588 583 584 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 599 605 595 601 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;1</label>
###xml 662 663 658 659 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 676 677 672 673 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 677 678 673 674 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 713 714 709 710 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 737 738 733 734 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 751 752 747 748 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 755 756 751 752 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 789 790 785 786 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 834 835 830 831 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 844 845 840 841 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 888 889 884 885 <sub xmlns:xlink="http://www.w3.org/1999/xlink">6</sub>
###xml 890 892 886 888 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4&#8722;</sup>
###xml 1038 1039 1033 1034 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1048 1049 1043 1044 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 1125 1126 1119 1120 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1145 1146 1139 1140 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 1148 1149 1142 1143 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 1188 1189 1180 1181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1198 1199 1190 1191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 605 1227 601 1219 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="39">Effect of lubiprostone on ion secretion in rat duodenum. <bold>a</bold> Duodenal HCO<sub>3</sub><sup>&#8722;</sup> secretion was measured as total CO<sub>2</sub> output using pH and CO<sub>2</sub> electrodes. <bold>b</bold> Cl<sup>&#8722;</sup> secretion was measured with a Cl<sup>&#8722;</sup>-selective electrode and expressed as net Cl<sup>&#8722;</sup> output. <bold>c</bold> Water secretion was measured using [Fe(CN)<sub>6</sub>]<sup>4&#8722;</sup> as a non-absorbable marker and expressed as net water output. Perfusion of lubiprostone (0.1&#8211;10&#160;&#956;M) concentration dependently increased total CO<sub>2</sub> output (<bold>a</bold>), whereas only low concentration of lubiprostone (0.1&#160;&#956;M) increased net Cl<sup>&#8722;</sup> and water output (<bold>b</bold>, <bold>c</bold>). Data are expressed as mean&#160;&#177;&#160;SEM (<italic>n</italic>&#160;=&#160;6). *&#160;<italic>P</italic>&#160;&lt;&#160;0.05 versus vehicle group</p>
###xml 605 1227 601 1219 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="39">Effect of lubiprostone on ion secretion in rat duodenum. <bold>a</bold> Duodenal HCO<sub>3</sub><sup>&#8722;</sup> secretion was measured as total CO<sub>2</sub> output using pH and CO<sub>2</sub> electrodes. <bold>b</bold> Cl<sup>&#8722;</sup> secretion was measured with a Cl<sup>&#8722;</sup>-selective electrode and expressed as net Cl<sup>&#8722;</sup> output. <bold>c</bold> Water secretion was measured using [Fe(CN)<sub>6</sub>]<sup>4&#8722;</sup> as a non-absorbable marker and expressed as net water output. Perfusion of lubiprostone (0.1&#8211;10&#160;&#956;M) concentration dependently increased total CO<sub>2</sub> output (<bold>a</bold>), whereas only low concentration of lubiprostone (0.1&#160;&#956;M) increased net Cl<sup>&#8722;</sup> and water output (<bold>b</bold>, <bold>c</bold>). Data are expressed as mean&#160;&#177;&#160;SEM (<italic>n</italic>&#160;=&#160;6). *&#160;<italic>P</italic>&#160;&lt;&#160;0.05 versus vehicle group</p></caption>
###xml 1227 1227 1219 1219 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="10620_2009_907_Fig1_HTML" id="MO1"/>
###xml 599 1227 595 1219 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig1"><label>Fig.&#160;1</label><caption><p textid="39">Effect of lubiprostone on ion secretion in rat duodenum. <bold>a</bold> Duodenal HCO<sub>3</sub><sup>&#8722;</sup> secretion was measured as total CO<sub>2</sub> output using pH and CO<sub>2</sub> electrodes. <bold>b</bold> Cl<sup>&#8722;</sup> secretion was measured with a Cl<sup>&#8722;</sup>-selective electrode and expressed as net Cl<sup>&#8722;</sup> output. <bold>c</bold> Water secretion was measured using [Fe(CN)<sub>6</sub>]<sup>4&#8722;</sup> as a non-absorbable marker and expressed as net water output. Perfusion of lubiprostone (0.1&#8211;10&#160;&#956;M) concentration dependently increased total CO<sub>2</sub> output (<bold>a</bold>), whereas only low concentration of lubiprostone (0.1&#160;&#956;M) increased net Cl<sup>&#8722;</sup> and water output (<bold>b</bold>, <bold>c</bold>). Data are expressed as mean&#160;&#177;&#160;SEM (<italic>n</italic>&#160;=&#160;6). *&#160;<italic>P</italic>&#160;&lt;&#160;0.05 versus vehicle group</p></caption><graphic position="anchor" xlink:href="10620_2009_907_Fig1_HTML" id="MO1"/></fig>
###xml 648 651 <span type="species:ncbi:10116">rat</span>
Lubiprostone (0.1-10 muM) concentration-dependently increased duodenal HCO3- secretion in comparison with the vehicle group (Fig. 1a). In contrast, net Cl- output was increased only by a low concentration (0.1 muM) of lubiprostone (Fig. 1b), accompanied by increased net water output (Fig. 1c). This result demonstrated that a low concentration (0.1 muM) of lubiprostone affects Cl- secretion, whereas a high concentration (10 muM) stimulates HCO3- secretion. Lubiprostone may thus either reciprocally activate HCO3- and Cl- secretion, or augmented HCO3- secretion may mask stimulated Cl- secretion.Fig. 1Effect of lubiprostone on ion secretion in rat duodenum. a Duodenal HCO3- secretion was measured as total CO2 output using pH and CO2 electrodes. b Cl- secretion was measured with a Cl--selective electrode and expressed as net Cl- output. c Water secretion was measured using [Fe(CN)6]4- as a non-absorbable marker and expressed as net water output. Perfusion of lubiprostone (0.1-10 muM) concentration dependently increased total CO2 output (a), whereas only low concentration of lubiprostone (0.1 muM) increased net Cl- and water output (b, c). Data are expressed as mean +/- SEM (n = 6). * P < 0.05 versus vehicle group
###end p 38
###begin p 39
###xml 57 58 57 58 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 71 72 71 72 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 72 73 72 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 108 109 108 109 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 132 133 132 133 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 146 147 146 147 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 150 151 150 151 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 184 185 184 185 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 229 230 229 230 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 239 240 239 240 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 283 284 283 284 <sub xmlns:xlink="http://www.w3.org/1999/xlink">6</sub>
###xml 285 287 285 287 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4&#8722;</sup>
###xml 433 434 432 433 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 443 444 442 443 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 520 521 518 519 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 540 541 538 539 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 543 544 541 542 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 583 584 579 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 593 594 589 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 43 46 <span type="species:ncbi:10116">rat</span>
Effect of lubiprostone on ion secretion in rat duodenum. a Duodenal HCO3- secretion was measured as total CO2 output using pH and CO2 electrodes. b Cl- secretion was measured with a Cl--selective electrode and expressed as net Cl- output. c Water secretion was measured using [Fe(CN)6]4- as a non-absorbable marker and expressed as net water output. Perfusion of lubiprostone (0.1-10 muM) concentration dependently increased total CO2 output (a), whereas only low concentration of lubiprostone (0.1 muM) increased net Cl- and water output (b, c). Data are expressed as mean +/- SEM (n = 6). * P < 0.05 versus vehicle group
###end p 39
###begin title 40
Effect of CFTR Inhibition on Lubiprostone-Induced Ion Secretion
###end title 40
###begin p 41
###xml 28 31 28 31 <sub xmlns:xlink="http://www.w3.org/1999/xlink">inh</sub>
###xml 83 84 83 84 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 84 85 84 85 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 214 215 213 214 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 215 216 214 215 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 233 234 232 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2</xref>
###xml 278 279 277 278 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 279 280 278 279 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 359 360 358 359 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 374 375 373 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2</xref>
###xml 575 576 574 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2</xref>
###xml 674 680 673 679 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;2</label>
###xml 733 734 732 733 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 734 735 733 734 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 763 764 762 763 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 791 794 790 793 <sub xmlns:xlink="http://www.w3.org/1999/xlink">inh</sub>
###xml 875 876 873 874 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 876 877 874 875 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 920 921 918 919 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 957 958 955 956 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 970 971 968 969 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 1107 1108 1103 1104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1117 1118 1113 1114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1147 1155 1143 1146 <sup xmlns:xlink="http://www.w3.org/1999/xlink"> &#8224;&#160;</sup>
###xml 1155 1156 1146 1147 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 680 1189 679 1180 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="42">Effect of CFTR inhibition on lubiprostone-induced HCO<sub>3</sub><sup>&#8722;</sup> secretion in rat duodenum. <bold>a</bold> CFTR was inhibited by CFTR<sub>inh</sub>-172 (1&#160;mg/kg, ip) 1&#160;h prior to the experiment. Lubiprostone (10&#160;&#956;M)-induced HCO<sub>3</sub><sup>&#8722;</sup> secretion was reduced by CFTR inhibition. <bold>b</bold> CFTR inhibition had no effect on Cl<sup>&#8722;</sup> secretion. <bold>c</bold> CFTR inhibition decreased water secretion and lubiprostone reversed the effect of CFTR inhibition. Data are expressed as mean&#160;&#177;&#160;SEM (<italic>n</italic>&#160;=&#160;6). *&#160;<italic>P</italic>&#160;&lt;&#160;0.05 versus vehicle group,<sup> &#8224;&#160;</sup><italic>P</italic>&#160;&lt;&#160;0.05 versus lubiprostone group</p>
###xml 680 1189 679 1180 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="42">Effect of CFTR inhibition on lubiprostone-induced HCO<sub>3</sub><sup>&#8722;</sup> secretion in rat duodenum. <bold>a</bold> CFTR was inhibited by CFTR<sub>inh</sub>-172 (1&#160;mg/kg, ip) 1&#160;h prior to the experiment. Lubiprostone (10&#160;&#956;M)-induced HCO<sub>3</sub><sup>&#8722;</sup> secretion was reduced by CFTR inhibition. <bold>b</bold> CFTR inhibition had no effect on Cl<sup>&#8722;</sup> secretion. <bold>c</bold> CFTR inhibition decreased water secretion and lubiprostone reversed the effect of CFTR inhibition. Data are expressed as mean&#160;&#177;&#160;SEM (<italic>n</italic>&#160;=&#160;6). *&#160;<italic>P</italic>&#160;&lt;&#160;0.05 versus vehicle group,<sup> &#8224;&#160;</sup><italic>P</italic>&#160;&lt;&#160;0.05 versus lubiprostone group</p></caption>
###xml 1189 1189 1180 1180 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="10620_2009_907_Fig2_HTML" id="MO2"/>
###xml 674 1189 673 1180 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig2"><label>Fig.&#160;2</label><caption><p textid="42">Effect of CFTR inhibition on lubiprostone-induced HCO<sub>3</sub><sup>&#8722;</sup> secretion in rat duodenum. <bold>a</bold> CFTR was inhibited by CFTR<sub>inh</sub>-172 (1&#160;mg/kg, ip) 1&#160;h prior to the experiment. Lubiprostone (10&#160;&#956;M)-induced HCO<sub>3</sub><sup>&#8722;</sup> secretion was reduced by CFTR inhibition. <bold>b</bold> CFTR inhibition had no effect on Cl<sup>&#8722;</sup> secretion. <bold>c</bold> CFTR inhibition decreased water secretion and lubiprostone reversed the effect of CFTR inhibition. Data are expressed as mean&#160;&#177;&#160;SEM (<italic>n</italic>&#160;=&#160;6). *&#160;<italic>P</italic>&#160;&lt;&#160;0.05 versus vehicle group,<sup> &#8224;&#160;</sup><italic>P</italic>&#160;&lt;&#160;0.05 versus lubiprostone group</p></caption><graphic position="anchor" xlink:href="10620_2009_907_Fig2_HTML" id="MO2"/></fig>
###xml 14 18 <span type="species:ncbi:10116">rats</span>
###xml 749 752 <span type="species:ncbi:10116">rat</span>
We pretreated rats with CFTRinh-172 in order to examine the function of CFTR in HCO3- secretion in response to perfusion of high concentration lubiprostone (10 muM). CFTR inhibition reduced lubiprostone-induced HCO3- secretion (Fig. 2a), suggesting that lubiprostone-induced HCO3- secretion is partially CFTR-dependent. CFTR inhibition had no effect on net Cl- output (Fig. 2b). Interestingly, CFTR inhibition decreased net water output during the basal period, with lubiprostone perfusion increasing net water output to the same level as measured in the vehicle group (Fig. 2c). This result suggests that lubiprostone reverses the effect of CFTR inhibition on water output.Fig. 2Effect of CFTR inhibition on lubiprostone-induced HCO3- secretion in rat duodenum. a CFTR was inhibited by CFTRinh-172 (1 mg/kg, ip) 1 h prior to the experiment. Lubiprostone (10 muM)-induced HCO3- secretion was reduced by CFTR inhibition. b CFTR inhibition had no effect on Cl- secretion. c CFTR inhibition decreased water secretion and lubiprostone reversed the effect of CFTR inhibition. Data are expressed as mean +/- SEM (n = 6). * P < 0.05 versus vehicle group, dagger P < 0.05 versus lubiprostone group
###end p 41
###begin p 42
###xml 53 54 53 54 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 54 55 54 55 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 83 84 83 84 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 111 114 111 114 <sub xmlns:xlink="http://www.w3.org/1999/xlink">inh</sub>
###xml 195 196 194 195 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 196 197 195 196 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 240 241 239 240 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 277 278 276 277 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 290 291 289 290 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 427 428 424 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 437 438 434 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 467 475 464 467 <sup xmlns:xlink="http://www.w3.org/1999/xlink"> &#8224;&#160;</sup>
###xml 475 476 467 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 69 72 <span type="species:ncbi:10116">rat</span>
Effect of CFTR inhibition on lubiprostone-induced HCO3- secretion in rat duodenum. a CFTR was inhibited by CFTRinh-172 (1 mg/kg, ip) 1 h prior to the experiment. Lubiprostone (10 muM)-induced HCO3- secretion was reduced by CFTR inhibition. b CFTR inhibition had no effect on Cl- secretion. c CFTR inhibition decreased water secretion and lubiprostone reversed the effect of CFTR inhibition. Data are expressed as mean +/- SEM (n = 6). * P < 0.05 versus vehicle group, dagger P < 0.05 versus lubiprostone group
###end p 42
###begin p 43
###xml 101 102 100 101 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 116 117 115 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig3" ref-type="fig">3</xref>
###xml 145 146 144 145 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 146 147 145 146 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 164 165 163 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig3" ref-type="fig">3</xref>
###xml 316 317 315 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig3" ref-type="fig">3</xref>
###xml 360 361 359 360 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 400 406 399 405 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;3</label>
###xml 458 459 457 458 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 555 556 553 554 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 568 569 566 567 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 596 597 594 595 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 597 598 595 596 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 610 611 608 609 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 686 687 684 685 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 726 727 722 723 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 736 737 732 733 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 767 773 763 764 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8224;</sup>
###xml 774 775 765 766 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 406 808 405 799 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="44">Effect of CFTR inhibition on lubiprostone-induced Cl<sup>&#8722;</sup> secretion in rat duodenum. CFTR inhibition tended to decrease lubiprostone (0.1&#160;&#956;M)-induced Cl<sup>&#8722;</sup> secretion (<bold>b</bold>), but had no effect on HCO<sub>3</sub><sup>&#8722;</sup> secretion (<bold>a</bold>). Lubiprostone reversed CFTR inhibition-induced decrease of water output (<bold>c</bold>). Data are expressed as mean&#160;&#177;&#160;SEM (<italic>n</italic>&#160;=&#160;6). *&#160;<italic>P</italic>&#160;&lt;&#160;0.05 versus vehicle group, <sup>&#8224;</sup>&#160;<italic>P</italic>&#160;&lt;&#160;0.05 versus lubiprostone group</p>
###xml 406 808 405 799 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="44">Effect of CFTR inhibition on lubiprostone-induced Cl<sup>&#8722;</sup> secretion in rat duodenum. CFTR inhibition tended to decrease lubiprostone (0.1&#160;&#956;M)-induced Cl<sup>&#8722;</sup> secretion (<bold>b</bold>), but had no effect on HCO<sub>3</sub><sup>&#8722;</sup> secretion (<bold>a</bold>). Lubiprostone reversed CFTR inhibition-induced decrease of water output (<bold>c</bold>). Data are expressed as mean&#160;&#177;&#160;SEM (<italic>n</italic>&#160;=&#160;6). *&#160;<italic>P</italic>&#160;&lt;&#160;0.05 versus vehicle group, <sup>&#8224;</sup>&#160;<italic>P</italic>&#160;&lt;&#160;0.05 versus lubiprostone group</p></caption>
###xml 808 808 799 799 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="10620_2009_907_Fig3_HTML" id="MO3"/>
###xml 400 808 399 799 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig3"><label>Fig.&#160;3</label><caption><p textid="44">Effect of CFTR inhibition on lubiprostone-induced Cl<sup>&#8722;</sup> secretion in rat duodenum. CFTR inhibition tended to decrease lubiprostone (0.1&#160;&#956;M)-induced Cl<sup>&#8722;</sup> secretion (<bold>b</bold>), but had no effect on HCO<sub>3</sub><sup>&#8722;</sup> secretion (<bold>a</bold>). Lubiprostone reversed CFTR inhibition-induced decrease of water output (<bold>c</bold>). Data are expressed as mean&#160;&#177;&#160;SEM (<italic>n</italic>&#160;=&#160;6). *&#160;<italic>P</italic>&#160;&lt;&#160;0.05 versus vehicle group, <sup>&#8224;</sup>&#160;<italic>P</italic>&#160;&lt;&#160;0.05 versus lubiprostone group</p></caption><graphic position="anchor" xlink:href="10620_2009_907_Fig3_HTML" id="MO3"/></fig>
###xml 473 476 <span type="species:ncbi:10116">rat</span>
In contrast, CFTR inhibition partially suppressed low concentration lubiprostone (0.1 muM)-induced Cl- output (Fig. 3b), but had no effect on HCO3- secretion (Fig. 3a). Again, CFTR inhibition decreased net water output during the basal period, and inhibited low concentration lubiprostone-induced water output (Fig. 3c), suggesting that lubiprostone-induced Cl- secretion is partially CFTR-dependent.Fig. 3Effect of CFTR inhibition on lubiprostone-induced Cl- secretion in rat duodenum. CFTR inhibition tended to decrease lubiprostone (0.1 muM)-induced Cl- secretion (b), but had no effect on HCO3- secretion (a). Lubiprostone reversed CFTR inhibition-induced decrease of water output (c). Data are expressed as mean +/- SEM (n = 6). * P < 0.05 versus vehicle group, dagger P < 0.05 versus lubiprostone group
###end p 43
###begin p 44
###xml 52 53 52 53 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 149 150 148 149 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 162 163 161 162 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 190 191 189 190 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 191 192 190 191 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 204 205 203 204 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 280 281 279 280 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 320 321 317 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 330 331 327 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 361 367 358 359 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8224;</sup>
###xml 368 369 360 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 67 70 <span type="species:ncbi:10116">rat</span>
Effect of CFTR inhibition on lubiprostone-induced Cl- secretion in rat duodenum. CFTR inhibition tended to decrease lubiprostone (0.1 muM)-induced Cl- secretion (b), but had no effect on HCO3- secretion (a). Lubiprostone reversed CFTR inhibition-induced decrease of water output (c). Data are expressed as mean +/- SEM (n = 6). * P < 0.05 versus vehicle group, dagger P < 0.05 versus lubiprostone group
###end p 44
###begin title 45
###xml 78 79 78 79 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 79 80 79 80 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
Effect of EP Receptor Antagonist or COX Inhibition on Lubiprostone-Induced HCO3- Secretion
###end title 45
###begin p 46
###xml 45 46 45 46 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 102 103 101 102 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 103 104 102 103 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 165 166 164 165 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 218 219 217 218 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 222 223 221 222 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 280 281 279 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig4" ref-type="fig">4</xref>
###xml 388 389 386 387 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 389 390 387 388 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 407 408 405 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig4" ref-type="fig">4</xref>
###xml 477 478 475 476 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 504 505 502 503 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 505 506 503 504 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 545 551 543 549 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;4</label>
###xml 651 652 649 650 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 652 653 650 651 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 681 682 679 680 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 749 750 746 747 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 750 751 747 748 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 862 863 857 858 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 872 873 867 868 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 902 909 897 899 <sup xmlns:xlink="http://www.w3.org/1999/xlink"> &#8224;</sup>
###xml 910 911 900 901 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 946 947 936 937 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 1096 1097 1085 1086 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1097 1098 1086 1087 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1146 1147 1133 1134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1156 1157 1143 1144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 551 1185 549 1172 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="47">Effect of prostaglandin receptor antagonist and cyclooxygenase inhibitor on lubiprostone-induced HCO<sub>3</sub><sup>&#8722;</sup> secretion in rat duodenum. <bold>a</bold> AH6809 (0.1&#160;mM) had no effect on lubiprostone (10&#160;&#956;M)-induced HCO<sub>3</sub><sup>&#8722;</sup> secretion, whereas AH23848 (0.1&#160;mM) abolished the effect of lubiprostone. Data are expressed as mean&#160;&#177;&#160;SEM (<italic>n</italic>&#160;=&#160;6). *&#160;<italic>P</italic>&#160;&lt;&#160;0.05 versus vehicle group,<sup> &#8224;</sup>&#160;<italic>P</italic>&#160;&lt;&#160;0.05 versus lubiprostone group. <bold>b</bold> Indomethacin (Indo, 5&#160;mg/kg, sc) was given 1&#160;h prior to the experiment. Indomethacin pretreatment had no effect on lubiprostone (10&#160;&#956;M)-induced HCO<sub>3</sub><sup>&#8722;</sup> secretion. Data are expressed as mean&#160;&#177;&#160;SEM (<italic>n</italic>&#160;=&#160;6). *&#160;<italic>P</italic>&#160;&lt;&#160;0.05 versus vehicle group</p>
###xml 551 1185 549 1172 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="47">Effect of prostaglandin receptor antagonist and cyclooxygenase inhibitor on lubiprostone-induced HCO<sub>3</sub><sup>&#8722;</sup> secretion in rat duodenum. <bold>a</bold> AH6809 (0.1&#160;mM) had no effect on lubiprostone (10&#160;&#956;M)-induced HCO<sub>3</sub><sup>&#8722;</sup> secretion, whereas AH23848 (0.1&#160;mM) abolished the effect of lubiprostone. Data are expressed as mean&#160;&#177;&#160;SEM (<italic>n</italic>&#160;=&#160;6). *&#160;<italic>P</italic>&#160;&lt;&#160;0.05 versus vehicle group,<sup> &#8224;</sup>&#160;<italic>P</italic>&#160;&lt;&#160;0.05 versus lubiprostone group. <bold>b</bold> Indomethacin (Indo, 5&#160;mg/kg, sc) was given 1&#160;h prior to the experiment. Indomethacin pretreatment had no effect on lubiprostone (10&#160;&#956;M)-induced HCO<sub>3</sub><sup>&#8722;</sup> secretion. Data are expressed as mean&#160;&#177;&#160;SEM (<italic>n</italic>&#160;=&#160;6). *&#160;<italic>P</italic>&#160;&lt;&#160;0.05 versus vehicle group</p></caption>
###xml 1185 1185 1172 1172 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="10620_2009_907_Fig4_HTML" id="MO4"/>
###xml 545 1185 543 1172 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig4"><label>Fig.&#160;4</label><caption><p textid="47">Effect of prostaglandin receptor antagonist and cyclooxygenase inhibitor on lubiprostone-induced HCO<sub>3</sub><sup>&#8722;</sup> secretion in rat duodenum. <bold>a</bold> AH6809 (0.1&#160;mM) had no effect on lubiprostone (10&#160;&#956;M)-induced HCO<sub>3</sub><sup>&#8722;</sup> secretion, whereas AH23848 (0.1&#160;mM) abolished the effect of lubiprostone. Data are expressed as mean&#160;&#177;&#160;SEM (<italic>n</italic>&#160;=&#160;6). *&#160;<italic>P</italic>&#160;&lt;&#160;0.05 versus vehicle group,<sup> &#8224;</sup>&#160;<italic>P</italic>&#160;&lt;&#160;0.05 versus lubiprostone group. <bold>b</bold> Indomethacin (Indo, 5&#160;mg/kg, sc) was given 1&#160;h prior to the experiment. Indomethacin pretreatment had no effect on lubiprostone (10&#160;&#956;M)-induced HCO<sub>3</sub><sup>&#8722;</sup> secretion. Data are expressed as mean&#160;&#177;&#160;SEM (<italic>n</italic>&#160;=&#160;6). *&#160;<italic>P</italic>&#160;&lt;&#160;0.05 versus vehicle group</p></caption><graphic position="anchor" xlink:href="10620_2009_907_Fig4_HTML" id="MO4"/></fig>
###xml 667 670 <span type="species:ncbi:10116">rat</span>
We next examined whether lubiprostone has PGE2 agonist-like effects. Lubiprostone (10 muM)-induced HCO3- secretion was abolished by the co-perfusion of the potent EP4 receptor antagonist AH23848 (0.1 mM), whereas an EP1/EP2 receptor antagonist AH6809 (0.1 mM) had no effect (Fig. 4a). Furthermore, indomethacin pretreatment (5 mg/kg, ip) had no effect on lubiprostone (10 muM)-induced HCO3- secretion (Fig. 4b). These results suggest that lubiprostone may directly stimulate EP4 receptors, increasing HCO3- secretion, rather than activating COX.Fig. 4Effect of prostaglandin receptor antagonist and cyclooxygenase inhibitor on lubiprostone-induced HCO3- secretion in rat duodenum. a AH6809 (0.1 mM) had no effect on lubiprostone (10 muM)-induced HCO3- secretion, whereas AH23848 (0.1 mM) abolished the effect of lubiprostone. Data are expressed as mean +/- SEM (n = 6). * P < 0.05 versus vehicle group, dagger P < 0.05 versus lubiprostone group. b Indomethacin (Indo, 5 mg/kg, sc) was given 1 h prior to the experiment. Indomethacin pretreatment had no effect on lubiprostone (10 muM)-induced HCO3- secretion. Data are expressed as mean +/- SEM (n = 6). * P < 0.05 versus vehicle group
###end p 46
###begin p 47
###xml 100 101 100 101 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 101 102 101 102 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 130 131 130 131 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 198 199 197 198 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 199 200 198 199 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 311 312 308 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 321 322 318 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 351 358 348 350 <sup xmlns:xlink="http://www.w3.org/1999/xlink"> &#8224;</sup>
###xml 359 360 351 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 395 396 387 388 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 545 546 536 537 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 546 547 537 538 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 595 596 584 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 605 606 594 595 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 116 119 <span type="species:ncbi:10116">rat</span>
Effect of prostaglandin receptor antagonist and cyclooxygenase inhibitor on lubiprostone-induced HCO3- secretion in rat duodenum. a AH6809 (0.1 mM) had no effect on lubiprostone (10 muM)-induced HCO3- secretion, whereas AH23848 (0.1 mM) abolished the effect of lubiprostone. Data are expressed as mean +/- SEM (n = 6). * P < 0.05 versus vehicle group, dagger P < 0.05 versus lubiprostone group. b Indomethacin (Indo, 5 mg/kg, sc) was given 1 h prior to the experiment. Indomethacin pretreatment had no effect on lubiprostone (10 muM)-induced HCO3- secretion. Data are expressed as mean +/- SEM (n = 6). * P < 0.05 versus vehicle group
###end p 47
###begin title 48
Discussion
###end title 48
###begin p 49
###xml 157 158 156 157 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 158 159 157 158 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 221 222 219 220 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 268 269 266 267 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 269 270 267 268 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 321 322 319 320 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 409 410 407 408 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 479 480 477 478 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 515 516 513 514 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 516 517 514 515 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 665 666 663 664 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 853 854 851 852 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
We demonstrated that luminally-perfused lubiprostone increased ion secretion with a concentration-related manner; a high concentration (10 muM) increased HCO3- secretion, whereas a low concentration (0.1 muM) increased Cl- and water secretion. Lubiprostone-induced HCO3- secretion was partially CFTR-dependent, whereas Cl- secretion was not apparently CFTR-dependent, presumably involving non-CFTR mediated Cl- secretion. High concentration lubiprostone may directly stimulate EP4 receptors, increasing duodenal HCO3- secretion. CFTR inhibition decreased net water output, reversed by a high or low concentration of lubiprostone, consistent with CFTR-independent Cl- secretion. This is the first study demonstrating that lubiprostone stimulates duodenal ion secretion in vivo. Furthermore, lubiprostone may act as a dual activator of CFTR-independent Cl- secretion and as a PG receptor agonist.
###end p 49
###begin p 50
###xml 60 61 60 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 188 189 188 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR1">1</xref>
###xml 254 255 254 255 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 299 301 299 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR13">13</xref>
###xml 470 471 470 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR1">1</xref>
###xml 605 606 605 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR6">6</xref>
###xml 608 610 608 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR20">20</xref>
###xml 667 668 667 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">4</xref>
###xml 701 702 701 702 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 710 711 710 711 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 711 712 711 712 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 817 818 817 818 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR6">6</xref>
###xml 985 986 985 986 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 986 987 986 987 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1070 1071 1070 1071 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
The mechanism by which lubiprostone stimulates intestinal Cl- secretion selectively via ClC-2 is controversial. Lubiprostone activates ClC-2 via a CFTR-independent mechanism in T84 cells [1]. In Ussing-chambered ileum and colon, lubiprostone increases Cl- secretion by a CFTR-independent mechanism [13]. Furthermore, the localization of ClC-2 in the intestinal epithelial cells is also controversial. Transfected T84 and MDCK cells express ClC-2 on the apical membrane [1], whereas immunohistochemistry on intact intestinal sections reveals the expression of ClC-2 on the enterocyte basolateral membrane [6, 20] or in the region of the intercellular tight junctions [4]. Since the duodenum secretes Cl- and HCO3- via a CFTR-dependent mechanism, whereas ClC-2 is localized on the basolateral membrane of duodenocytes [6], we assessed the involvement of CFTR in duodenal lubiprostone-induced ion secretion. Our results demonstrated that at high concentration, lubiprostone stimulated HCO3- secretion via a CFTR-dependent mechanism, whereas a low concentration increased Cl- secretion via a CFTR-independent mechanism.
###end p 50
###begin p 51
###xml 107 108 107 108 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 110 112 110 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR21">21</xref>
###xml 281 282 281 282 <sub xmlns:xlink="http://www.w3.org/1999/xlink">B</sub>
###xml 295 297 295 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR22">22</xref>
###xml 338 339 338 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink">I</italic>
###xml 339 341 339 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sc</italic>
###xml 339 341 339 341 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>sc</italic></sub>
###xml 416 418 416 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR13">13</xref>
###xml 486 487 486 487 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 487 488 487 488 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 521 522 521 522 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 547 548 547 548 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 551 552 551 552 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 598 599 598 599 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 641 643 641 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR23">23</xref>
###xml 680 682 680 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR24">24</xref>
###xml 703 704 703 704 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 704 705 704 705 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 753 754 753 754 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 224 227 <span type="species:ncbi:10116">rat</span>
###xml 354 364 <span type="species:ncbi:10141">guinea pig</span>
Furthermore, the site of lubiprostone action is still controversial. Since lubiprostone is derived from PGE1 [21], it may activate EP receptors. Indeed, EP receptor antagonists diminished lubiprostone-induced contraction of rat gastric and colonic smooth muscle with an apparent pKB of 6.7-7.6 [22]. In contrast, the lubiprostone-induced Isc increase in guinea pig colon was not affected by EP receptor antagonists [13]. Our results show that high concentration lubiprostone-induced HCO3- secretion is mediated via the EP4 receptor, but not via EP1/EP2 or endogenous PGs by COX activation. Since EP4 activation increases intracellular cAMP [23], and elevated cAMP activates CFTR [24], CFTR-dependent HCO3- secretion by lubiprostone is consistent with EP4 receptor activation by lubiprostone.
###end p 51
###begin p 52
###xml 110 111 110 111 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 157 158 157 158 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 158 159 158 159 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 425 426 425 426 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 615 616 615 616 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 923 924 923 924 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 979 981 979 981 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR25">25</xref>
###xml 173 176 <span type="species:ncbi:10116">rat</span>
###xml 698 702 <span type="species:ncbi:10090">mice</span>
###xml 707 713 <span type="species:ncbi:9606">humans</span>
###xml 786 790 <span type="species:ncbi:10090">mice</span>
Taken together, our results support the hypothesis that high concentration lubiprostone directly stimulates EP4 receptors, activating CFTR and increasing HCO3- secretion in rat duodenum. Existing controversies regarding the CFTR dependence of lubiprostone action might reflect species, intestinal segment, and concentration differences. Our results also support the hypothesis that low concentration lubiprostone activates Cl- secretion via non-CFTR channels. Unfortunately, the lack of selective ClC-2 inhibitors impedes further characterization of the mechanism by which low concentration lubiprostone augments Cl- secretion. Very recent data generated from mucosal biopsies obtained from normal mice and humans and those homozygous for CFTR loss-of-function mutations, and CFTR null mice strongly implicated the CFTR in lubiprostone-stimulated anion secretion. Furthermore, this secretion was significantly reduced by EP4 receptor antagonists, as is consistent with our data [25].
###end p 52
###begin p 53
###xml 22 23 22 23 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 23 24 23 24 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 556 557 553 554 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 201 207 <span type="species:ncbi:9606">humans</span>
Increased duodenal HCO3- secretion induced by a high concentration of lubiprostone (10 muM) may protect the mucosa from acid-induced injury. Although the exact luminal concentration of lubiprostone in humans is not available, the recommended dose (24 mug; ~60 nmol) may produce duodenal luminal concentrations to the dose we tested (10 nmol/min). Since duodenal luminal concentrations are no doubt higher than in the distal gut, the 24 mug dose may protect the gastroduodenal mucosa. In the distal gut, the lower lubiprostone concentrations may increase Cl- secretion.
###end p 53
###begin p 54
###xml 95 96 95 96 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 98 99 98 99 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 143 145 143 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR26">26</xref>
###xml 159 160 159 160 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 322 323 322 323 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 426 427 426 427 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 449 450 449 450 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 450 451 450 451 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 499 500 499 500 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 594 595 594 595 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 595 596 595 596 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 630 631 630 631 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 686 687 686 687 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 857 858 857 858 <italic xmlns:xlink="http://www.w3.org/1999/xlink">I</italic>
###xml 858 860 858 860 <sub xmlns:xlink="http://www.w3.org/1999/xlink">sc</sub>
###xml 891 893 891 893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR13">13</xref>
###xml 873 883 <span type="species:ncbi:10141">guinea pig</span>
CFTR inhibition decreased water output, presumably explained by the reciprocal activation of Na+/H+ exchanger-3 (NHE3) on the apical membrane [26] mediating Na+ absorption followed by water absorption. Recovery of water output by low concentration lubiprostone during CFTR inhibition is consistent with CFTR-independent Cl- secretion. ClC-2 channels, due to their basolateral location in the duodenum, may increase duodenal Cl- absorption during HCO3- secretion as an alternative to CFTR-mediated Cl- recycling across the apical membrane. Furthermore, lubiprostone stimulates CFTR-dependent HCO3- secretion without changing net Cl- secretion. This effect supports the hypothesis that Cl- secreted by CFTR is recycled across the apical membrane by anion exchangers. Interestingly, the non-specific anion exchange inhibitor DIDS inhibits lubiprostone-induced Isc increase in guinea pig ileum [13], also supporting this hypothesis.
###end p 54
###begin p 55
###xml 173 174 173 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink">I</italic>
###xml 174 176 174 176 <sub xmlns:xlink="http://www.w3.org/1999/xlink">sc</sub>
###xml 344 346 344 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR27">27</xref>
CFTR-dependent and -independent actions of lubiprostone may be beneficial for other organs, which manifest the CF phenotype. Recently, lubiprostone was reported to increase Isc and mucus secretion via CFTR-dependent and -independent pathways in airway submucosal glands, suggesting it might be of benefit outside of the gastrointestinal tract [27].
###end p 55
###begin p 56
###xml 51 52 51 52 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 52 53 52 53 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 60 61 60 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 150 151 150 151 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 151 152 151 152 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 371 379 <span type="species:ncbi:9606">patients</span>
In conclusion, lubiprostone stimulates duodenal HCO3- and Cl- secretion via different pathways, dependent on its concentration. Increased duodenal HCO3- secretion suggests that lubiprostone may protect the duodenum from acid-induced injury. Restoration of impaired water output during CFTR inhibition suggests that lubiprostone may improve the intestinal phenotype in CF patients.
###end p 56
###begin p 57
We thank Jenifer Kugler for her assistance with manuscript preparation. This work was supported by a research grant from Takeda North America No. 07-014L, Department of Veterans Affairs Merit Review Award, NIH-NIDDK R01 DK54221 (J. Kaunitz), and the animal core of NIH-NIDDK P30 DK0413 (J. E. Rozengurt).
###end p 57
###begin p 58
###xml 0 11 0 11 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Open Access</bold>
Open Access This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
###end p 58
###begin title 59
References
###end title 59
###begin article-title 60
###xml 63 68 <span type="species:ncbi:9606">human</span>
SPI-0211 activates T84 cell chloride transport and recombinant human ClC-2 chloride currents
###end article-title 60
###begin article-title 61
A chloride channel widely expressed in epithelial and non-epithelial cells
###end article-title 61
###begin article-title 62
CLC chloride channels and transporters
###end article-title 62
###begin article-title 63
###xml 48 54 <span type="species:ncbi:10090">murine</span>
Expression of the chloride channel ClC-2 in the murine small intestine epithelium
###end article-title 63
###begin article-title 64
ClC-2 chloride secretion mediates prostaglandin-induced recovery of barrier function in ischemia-injured porcine ileum
###end article-title 64
###begin article-title 65
Basolateral localization of native ClC-2 chloride channels in absorptive intestinal epithelial cells and basolateral sorting encoded by a CBS-2 domain di-leucine motif
###end article-title 65
###begin article-title 66
###xml 37 38 37 38 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 152 157 <span type="species:ncbi:10090">mouse</span>
Additional disruption of the ClC-2 Cl- channel does not exacerbate the cystic fibrosis phenotype of cystic fibrosis transmembrane conductance regulator mouse models
###end article-title 66
###begin article-title 67
The chloride channel ClC-4 co-localizes with cystic fibrosis transmembrane conductance regulator and may mediate chloride flux across the apical membrane of intestinal epithelia
###end article-title 67
###begin article-title 68
###xml 48 49 48 49 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
Is the ClC-2 chloride channel involved in the Cl- secretory mechanism of gastric parietal cells?
###end article-title 68
###begin article-title 69
Effect of a selective chloride channel activator, lubiprostone, on gastrointestinal transit, gastric sensory, and motor functions in healthy volunteers
###end article-title 69
###begin article-title 70
###xml 32 40 <span type="species:ncbi:9606">patients</span>
Clinical trial: lubiprostone in patients with constipation-associated irritable bowel syndrome-results of two randomized, placebo-controlled studies
###end article-title 70
###begin article-title 71
Clinical trial: phase 2 study of lubiprostone for irritable bowel syndrome with constipation
###end article-title 71
###begin article-title 72
###xml 63 73 <span type="species:ncbi:10141">guinea pig</span>
Stimulation of mucosal secretion by lubiprostone (SPI-0211) in guinea pig small intestine and colon
###end article-title 72
###begin article-title 73
Gastroduodenal mucus bicarbonate barrier: protection against acid and pepsin
###end article-title 73
###begin article-title 74
###xml 52 53 52 53 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 53 54 53 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 97 101 <span type="species:ncbi:10116">rats</span>
A novel small molecule CFTR inhibitor attenuates HCO3- secretion and duodenal ulcer formation in rats
###end article-title 74
###begin article-title 75
###xml 42 43 42 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 45 46 45 46 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 68 71 <span type="species:ncbi:10116">rat</span>
Epithelial carbonic anhydrases facilitate PCO2 and pH regulation in rat duodenal mucosa
###end article-title 75
###begin article-title 76
###xml 96 100 <span type="species:ncbi:10116">rats</span>
Duodenal brush border intestinal alkaline phosphatase activity affects bicarbonate secretion in rats
###end article-title 76
###begin article-title 77
###xml 59 62 <span type="species:ncbi:10116">rat</span>
Luminal nutrients alter tight-junction permeability in the rat jejunum: an in vivo perfusion model
###end article-title 77
###begin article-title 78
###xml 68 71 <span type="species:ncbi:10116">rat</span>
Sensory pathways and cyclooxygenase regulate mucus gel thickness in rat duodenum
###end article-title 78
###begin article-title 79
###xml 42 45 <span type="species:ncbi:10116">rat</span>
###xml 50 55 <span type="species:ncbi:9606">human</span>
Distribution of ClC-2 chloride channel in rat and human epithelial tissues
###end article-title 79
###begin article-title 80
Clinical pharmacology of lubiprostone, a chloride channel activator in defecation disorders
###end article-title 80
###begin article-title 81
###xml 60 63 <span type="species:ncbi:10116">rat</span>
###xml 68 73 <span type="species:ncbi:9606">human</span>
Activation of prostaglandin EP receptors by lubiprostone in rat and human stomach and colon
###end article-title 81
###begin article-title 82
EP2 and EP4 prostanoid receptor signaling
###end article-title 82
###begin article-title 83
Macromolecular complexes of cystic fibrosis transmembrane conductance regulator and its interacting partners
###end article-title 83
###begin article-title 84
###xml 61 62 61 62 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 75 78 <span type="species:ncbi:10116">rat</span>
CFTR inhibition augments NHE3 activity during luminal high CO2 exposure in rat duodenal mucosa
###end article-title 84
###begin article-title 85
###xml 69 74 <span type="species:ncbi:9940">sheep</span>
###xml 76 80 <span type="species:ncbi:9823">pigs</span>
###xml 86 92 <span type="species:ncbi:9606">humans</span>
Lubiprostone stimulates secretion from tracheal submucosal glands of sheep, pigs, and humans
###end article-title 85

